Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods.

[1]  Ichiro Katayama,et al.  Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. , 2015, Biomaterials.

[2]  Parminder Singh,et al.  Fabrication of cell culture-derived influenza vaccine dissolvable microstructures and evaluation of immunogenicity in guinea pigs. , 2015, Vaccine.

[3]  G. Carnell,et al.  Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis , 2015, Front. Immunol..

[4]  D. McAllister,et al.  Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature , 2015, Drug Delivery and Translational Research.

[5]  A. Hill,et al.  Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases. , 2015, The Lancet. Infectious diseases.

[6]  Mark R Prausnitz,et al.  Development of a thermostable microneedle patch for influenza vaccination. , 2015, Journal of pharmaceutical sciences.

[7]  Carl W Davis,et al.  Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans , 2014, Proceedings of the National Academy of Sciences.

[8]  C. O’Mahony,et al.  Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route , 2014, Scientific Reports.

[9]  E. Montomoli,et al.  Discordant Correlation between Serological Assays Observed When Measuring Heterosubtypic Responses against Avian Influenza H5 and H7 Viruses in Unexposed Individuals , 2014, BioMed research international.

[10]  Mark R Prausnitz,et al.  Microneedle patches: usability and acceptability for self-vaccination against influenza. , 2014, Vaccine.

[11]  Conor O'Mahony,et al.  Structural characterization and in-vivo reliability evaluation of silicon microneedles , 2014, Biomedical Microdevices.

[12]  Conor O'Mahony,et al.  Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  R. Rappuoli,et al.  Correlates of protection against influenza infection in humans--on the path to a universal vaccine? , 2013, Current opinion in immunology.

[14]  P. Dormitzer,et al.  Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. , 2013, Vaccine.

[15]  S. Draper,et al.  Utilizing poxviral vectored vaccines for antibody induction—Progress and prospects , 2013, Vaccine.

[16]  P. Lydon,et al.  Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020. , 2013, Vaccine.

[17]  E. Böttcher-Friebertshäuser,et al.  The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes , 2013, Journal of molecular and genetic medicine : an international journal of biomedical research.

[18]  D. Rhodes,et al.  Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability , 2012, BMC Biotechnology.

[19]  Mark R. Prausnitz,et al.  Effect of Adjuvants on Responses to Skin Immunization by Microneedles Coated with Influenza Subunit Vaccine , 2012, PloS one.

[20]  Conor O'Mahony,et al.  Coated microneedle arrays for transcutaneous delivery of live virus vaccines. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[21]  Mark R. Prausnitz,et al.  Local Response to Microneedle-Based Influenza Immunization in the Skin , 2012, mBio.

[22]  I. Frazer,et al.  Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Adolfo García-Sastre,et al.  Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses , 2012, Proceedings of the National Academy of Sciences.

[24]  E. R. van den Heuvel,et al.  Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay. , 2012, Vaccine.

[25]  J. Stockman,et al.  Dissolving polymer microneedle patches for influenza vaccination , 2012 .

[26]  A. Steven,et al.  Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines. , 2011, Vaccine.

[27]  A. Crean,et al.  Microneedle Array Design Determines the Induction of Protective Memory CD8+ T Cell Responses Induced by a Recombinant Live Malaria Vaccine in Mice , 2011, PloS one.

[28]  H. McShane,et al.  Tuberculosis vaccines in clinical trials , 2011, Expert review of vaccines.

[29]  David M Martin,et al.  Drug-eluting stents for coronary artery disease: a review. , 2011, Medical engineering & physics.

[30]  N. Nundy,et al.  Incremental costs of introducing jet injection technology for delivery of routine childhood vaccinations: comparative analysis from Brazil, India, and South Africa. , 2011, Vaccine.

[31]  J. Yewdell,et al.  Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection , 2011, The Journal of experimental medicine.

[32]  H. L. Glansbeekb,et al.  Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay , 2011 .

[33]  Mark R Prausnitz,et al.  Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Conor O'Mahony,et al.  In-vivo dynamic characterization of microneedle skin penetration using optical coherence tomography. , 2010, Journal of biomedical optics.

[35]  T. Prow,et al.  The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine. , 2010, Biomaterials.

[36]  Mark R. Prausnitz,et al.  Intradermal Vaccination with Influenza Virus-Like Particles by Using Microneedles Induces Protection Superior to That with Intramuscular Immunization , 2010, Journal of Virology.

[37]  Mark R. Prausnitz,et al.  Dissolving Polymer Microneedle Patches for Influenza Vaccination , 2010, Nature Medicine.

[38]  Mark R Prausnitz,et al.  Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[39]  A. Hill,et al.  Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass , 2010, Science Translational Medicine.

[40]  R. Rappuoli,et al.  Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus , 2010, Science Translational Medicine.

[41]  A. Folgori,et al.  Prime-boost vectored malaria vaccines: Progress and prospects , 2010, Human vaccines.

[42]  A. Hill,et al.  Alcock Vectors at Supraphysiological Temperatures in Carbohydrate Glass Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine , 2010 .

[43]  M. Prausnitz,et al.  Stability Kinetics of Influenza Vaccine Coated onto Microneedles During Drying and Storage , 2010, Pharmaceutical Research.

[44]  J. Matriano,et al.  Parathyroid Hormone (1-34)-Coated Microneedle Patch System: Clinical Pharmacokinetics and Pharmacodynamics for Treatment of Osteoporosis , 2010, Pharmaceutical Research.

[45]  M. Prausnitz,et al.  Stabilization of Influenza Vaccine Enhances Protection by Microneedle Delivery in the Mouse Skin , 2009, PloS one.

[46]  P. van Damme,et al.  Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. , 2009, Vaccine.

[47]  Jung-Hwan Park,et al.  Dissolving microneedles for transdermal drug delivery. , 2008, Biomaterials.

[48]  Mark R Prausnitz,et al.  Minimally Invasive Protein Delivery with Rapidly Dissolving Polymer Microneedles , 2008, Advanced materials.

[49]  G. Glenn,et al.  Transcutaneous delivery and thermostability of a dry trivalent inactivated influenza vaccine patch , 2008, Influenza and other respiratory viruses.

[50]  R. Hutubessy,et al.  Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. , 2008, Bulletin of the World Health Organization.

[51]  R. Weiss,et al.  A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies , 2007, Influenza and other respiratory viruses.

[52]  Yong-Kyu Yoon,et al.  Polymer particle-based micromolding to fabricate novel microstructures , 2007, Biomedical microdevices.

[53]  Mark R. Prausnitz,et al.  Coating Formulations for Microneedles , 2007, Pharmaceutical Research.

[54]  Mark R Prausnitz,et al.  Coated microneedles for transdermal delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[55]  N. Wilke,et al.  Process optimization and characterization of silicon microneedles fabricated by wet etch technology , 2005, Microelectron. J..

[56]  Jung-Hwan Park,et al.  Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[57]  P. Perrin,et al.  Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. , 2005, Immunity.

[58]  R. Nuzzo,et al.  A method for filling complex polymeric microfluidic devices and arrays. , 2001, Analytical chemistry.

[59]  Y. Hutin,et al.  Injection safety: a global challenge. , 1999, Bulletin of the World Health Organization.

[60]  Wagner,et al.  Stabilization of gene delivery systems by freeze-drying. , 1997, International journal of pharmaceutics.

[61]  V. Seagroatt,et al.  An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. , 1977, Journal of biological standardization.

[62]  V. Seagroatt,et al.  Application of an improved single-radial-immunodiffusion technique for the assay of haemagglutinin antigen content of whole virus and subunit influenza vaccines. , 1977, Developments in biological standardization.